The results from the Cox regression analysis demonstrated that an elevated expression of SMURF2 had a negative correlation with the survival time of patients with pancreatic cancer (Figure 1), which is of great importance for predicting patient survival. The gene discussed is SMURF2; the disease is pancreatic neoplasm.